California Department of Justice suing pharmaceutical companies over high insulin costs

California Atty. Gen. Rob Bonta said that Eli Lilly, Sanofi and Novo Nordisk are finding ways to “aggressively hike” the price of insulin at the expense of many patients.

Source: Los Angeles Times